Ever since the multiple roles and widespread overexpression of EEF1A2 in carcinomas have been identified, efforts have been made to target it for anticancer therapy utilizing miRNAs, natural products, and drugs [20–22]. The gene discussed is EEF1A2; the disease is carcinoma.